Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 235,712,874 papers from all fields of science
Search
Sign In
Create Free Account
cyclophosphamide/doxorubicin/etoposide/methotrexate/prednisone protocol
Known as:
CTX/DOX/MTX/PRED/VP-16
, Cyclophosphamide/Doxorubicin/Etoposide/Methotrexate/Prednisone
, ProMACE
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Cyclophosphamide
Doxorubicin
Doxorubicin Hydrochloride
Etoposide
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Relapsed CNS lymphoma after HD-MTX and WBRT successfully treated with modified ProMACE-MOPP
K. Fujino
2019
Corpus ID: 216571209
2016
2016
Superiority of ProMACE-CytaBOM Over ProMACE-MOPP in the Treatment of Advanced Diffuse Aggressive Lymphoma
D. Longo
,
V. Devita
,
+8 authors
R. Young
2016
Corpus ID: 78855163
Table of the report entitled "Superiority of ProMACE-CytaBOM Over ProMACE-MOPP in the Treatment of Advanced Diffuse Aggressive…
Expand
2006
2006
Randomized controlled study of proMACE-CytaBOM regimen in treatment of patients with relapsed or refractory intermediate and high grade non-Hodgkin’s lymphoma
G. Qi
2006
Corpus ID: 76447354
OBJECTIVE:To observe the clinical effect and toxicity of ProMACE-CytaBOM regimen in the treatment of patients with relapsed or…
Expand
2005
2005
Efficacy of Improved ProMACE/CytaBOM Regimen in Treatment of High Malignant and Middle Malignant Non-Hodgkin′s Lymphoma
Zheng Mei-fang
2005
Corpus ID: 76433280
Objective: To evaluate the efficacy of improved ProMACE/CytaBOM regimen in the treatment of high malignant and middle malignant…
Expand
2003
2003
Effect of ProMACE/CytaBOM regimen in treatment of refractory or relapse non-Hodgkin's lymphoma
Wang Shuhong
2003
Corpus ID: 76436726
Objective:To elucidate the effect of ProMACE/CytaBOM regimen in treatment of refractory and relapse non-Hodgkin's lymphoma…
Expand
2000
2000
ProMACE/CytaBOM Chemotherapy for Intermediate and High Grade Maliganant mon Hodgkin's Lymphoma
Ye Shu
2000
Corpus ID: 75392167
Objective:Evaluation of clinical response and toxic effects of ProMACE/CytaBOM in non Hodgkin's lymphoma.Methods:Among the 34…
Expand
1998
1998
A phase I trial of high dose ProMACE-CytaBOM with granulocyte colony stimulating factor for patients with non-Hodgkin's lymphoma.
T. Witzig
,
J. Camoriano
,
G. Schroeder
,
Paul J. Kurtin
,
T. Habermann
Leukemia and Lymphoma
1998
Corpus ID: 24631497
We hypothesized that the conventional ProMACE-CytaBOM regimen could be improved by administering all drugs on d1 with the S-phase…
Expand
1991
1991
Salvage therapy with PROMACE in relapsed non‐Hodgkin malignant lymphoma
H. Nielsen
European Journal of Haematology
1991
Corpus ID: 34630470
References Correspondence : M. Wernli, A. Tichelli, M. von Planta, A. Gratwohl, B. Speck Division of Haematology, Dept. Of…
Expand
1991
1991
Clinical effect of recombinant human granulocyte-stimulating factor in non-Hodgkin malignant lymphoma.
M. Okabe
,
K. Sakurada
,
Masanobu Kobayashi
,
I. Saiki
,
K. Matsuno
,
T. Minagawa
1991
Corpus ID: 74833190
To evaluate the clinical effect by administration of recombinant human granulocyte-stimulating factor (rhG-CS) post chemotherapy…
Expand
1985
1985
ProMACE-MOPP combination chemotherapy for diffuse lymphomas.
R. Fisher
,
R. Young
,
D. Longo
,
V. Devita
Seminars in Oncology
1985
Corpus ID: 12460826
Until the mid 1960s the advanced stage, high grade non-Hodgkin's lymphomas were rapidly progressive, fatal diseases with few…
Expand